This KOL commentary presented by Prof. Angelica Nogueira-Rodrigues and moderated by Prof. Lucia Del Mastro focused on the importance of treatment adherence in breast cancer patients using CDK 4/6 inhibitors, discussing factors influencing adherence, barriers, and strategies to improve it.
2:05 -Â Highlighting the importance of medication coverage in low and middle-income countries for patient adherence.
2:50 -Â Understanding the multifactorial causes of non-adherence, including financial problems, psychological impact, and physical impact.
8:06 -Â Emphasizing financial toxicity as a major barrier to access and adherence in low and middle-income countries.
8:16 -Â Identifying side effects such as fatigue, cognitive dysfunction, diarrhea, nausea, and myelotoxicity as factors influencing adherence to CDK 4/6 inhibitors.
10:02 -Â Implementing patient education programs to improve understanding of disease, treatment relevance, early recognition of side effects, and management strategies.
10:33 -Â Using simplified dosing regimens to enhance adherence and incorporating medication reminders for better adherence management.